Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor

Journal of Cellular Physiology

Volumn 179, Issue 1, 1999, Pages 52-57

  Ouyang, Xiaomei ^a   Gulliford, Timothy ^a   Huang, Guocai ^a   Epstein, Richard J ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL GROWTH; DOWN REGULATION; GROWTH REGULATION; ISOELECTRIC POINT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0032974814     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199904)179:1<52::AID-JCP7>3.0.CO;2-M     Document Type: Article

References (35)

1. Barnard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ. 1995. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 108: 564-580.
2. Campos-Gonzalez R, Glenney JR. 1991. Immunodetection of the ligand-activated receptor for epidermal growth factor. Growth Factors 4:305-316.
3. Chen C, Okayama H. 1987. High-efficiencv transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
4. Decker SJ. 1990. Epidermal growth factor and transforming growth factor-alpha induce differential processing of the epidermal growth factor receptor. Biochem Biophys Res Commun 166:615-621.
5. Decker SJ, Alexander C, Habib T. 1992. Epidermal growth factor (EGF)-stimulated tyrosine phosphorylation and EGF receptor degradation in cells expressing EGF receptors truncated at residue 973. J Biol Chem 267:1104-1108.
6. Ebner R, Derynck R. 1991. Epidermal growth factor and transforming growth factor-a: differential intracellular routing and processing of ligand-receptor complexes. Cell Regul 2:599-612.
7. Epstein RJ, Druker BJ, Roberts TM, Stiles CD. 1992. Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor. Proc Natl Acad Sci U S A 89:10435-10439.
8. Felder S, Miller K, Moehren G, Ullrich A, Schlessinger J, Hopkins CR. 1990. Kinase activity controls the sorting of epidermal growth factor receptor within the multivesicular body. Cell 61:623-634.
9. French AR, Tadaki DK, Niyogi SK, Lauffenburger DA. 1995. Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J Biol Chem 270:4334-4340.
10. Gulliford T, Huang GC, Ouyang X, Epstein RJ. 1997. Reduced ability of transforming growth factor-alpha to induce hetero-oligomerization and downregulation of EGFR suggests a mechanism of oncogenic synergy with ErbB2. Oncogene 15:2219-2223.
11. Hazan R, Margolis B, Dombalagian M, Ullrich A, Zilberstein A, Schlessinger J. 1990. Identification of autophosphorylation sites of HER2/neu. Cell Growth Differ 1:3-7.
12. Helin K, Beguinot L. 1991. Internalization and down-regulation of the human epidermal growth factor receptor are regulated by the carboxyl-terminal tyrosines. J Biol Chem 266:8363-8368.
13. Huang GC, Ouyang X, Epstein RJ. 1998. Proxy activation of ErbB2 by heterologous ligands suggests a heterotetrameric mechanism of receptor tyrosine kinase interaction. Biochem J 331:113-119.
14. Huang GC, Chantry A, Ouyang X, Epstein RJ. Overexpression of ErbB2 impairs downregulation of epidermal growth factor receptors via a post-transcriptional mechanism. J Cell Biochem (in press).
15. Kawamoto T, Sato JD. 1983. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci USA 80:1337-1341.
16. Kokai Y, Myers JM, Wada T, Brown VI, LeVea CM, Davis JG, Dobashi K, Greene MI. 1989. Synergistic interaction of p185/c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 58:287-292.
17. Korc M, Finman JE. 1989. Attenuated processing of epidermal growth factor in the face of marked degradation of transforming growth factor-alpha. J Biol Chem 264:14990-14999.
18. Kornilova E, Sorkina T, Beguinot L, Sorkin A. 1996. Lysosomal targeting of epidermal growth factor receptors via a kinase-dependent pathway is mediated by the receptor carboxyterminal residues 1022-1123. J Biol Chem 271:30340-30346.
19. Lee DC, Fenton SE, Berkowitz EA, Hissong MA. 1995. Transforming growth factor a: expression, regulation and biological activities. Pharmacol Rev 47:51-85.
20. Lenferink A, Pinkas-Kramarski R, van de Poll ML, van Vugt MJ, Klapper LN, Tzahar E, Waterman H, Sela M, van Zoelen EJ, Yarden Y. 1998. Differential endocytic routing of homo- and heterodimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers. EMBO J 17:3385-3397.
21. Li Y, Montelione GT. 1995. Human type-α transforming growth factor undergoes slow conformational exchange between multiple backbone conformations as characterized by nitrogen-15 relaxation measurements. Biochemistry 34:2408-2423.
22. Lippincott-Schwartz J, Yuan L, Tipper C, Amherdt M, Orci L, Klausner RD. 1991. Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell 67:601-616.
23. Muller WJ, Arteaga CL, Muthuswamy SK, Siegel PM, Webster MA, Cardiff RD, Meise KS, Li F, Halter SA, Coffrey RJ. 1996. Synergistic interaction of the neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice. Mol Cell Biol 16:5726-5736.
24. Nunez M, Mayo KH, Starbuck C, Lauffenburger D. 1993. pH sensitivity of epidermal growth factor receptor complexes. J Cell Biochem 51:312-321.
25. Ouyang X, Gulliford T, Zhang GC, Huang GC, Epstein R. 1996. Human cancer cells exhibit protein kinase C-dependent c-erbB-2 transmodulation which correlate with phosphatase sensitivity and kinase activity. J Biol Chem 271:21786-21792.
26. Ouyang X, Huang GC, Epstein RJ. 1998. Adjacent carboxyterminal tyrosine phosphorylation events identify functionally distinct ErbB2 receptor subsets. Exp Cell Res 241:467-475.
27. Pelham HRB. 1991. Multiple targets for brefeldin A. Cell 67:449-451.
28. Reddy CC, Wells A, Lauffenburger DA. 1996. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor-alpha. J Cell Physiol 166:512-522.
29. Reiss M, Stash EB, Vellucci VF, Zhou ZL. 1991. Activation of the autocrine transforming growth factor alpha pathway in human squamous carcinoma cells. Cancer Res 51:6254-6262.
30. Shome K, Xu XU, Romero G. 1995. Brefeldin A inhibits insulin-dependent receptor redistribution in HIRcB cells. FEBS Lett 357: 109-114.
31. Sorkin A, Waters CM. 1993. Endocytosis of growth factor receptors. Bioessays 15:375-382.
32. neu: a potential model for receptor interactions. EMBO J 7:995-1001.
33. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
34. van de Vijver MJ, Kumar R, Mendelsohn J. 1991. Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly. J Biol Chem 266:7503-7508.
35. Wiley HS, Herbst JJ, Walsh BJ, Lauffenburger DA, Rosenfeld MG, Gill GN. 1991. The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J Biol Chem 266:11083-11094.